University Of Washington

This early-stage study tested the safety and best dose of a two-drug immunotherapy combination for people with advanced kidney cancer that has spread. The trial combined pembrolizumab, a drug that helps the immune system attack cancer, with aldesleukin, which stimulates immune ce…

This study tested whether pembrolizumab, an immunotherapy drug, could help control certain slow-growing B-cell lymphomas in people who hadn't yet received any treatment. The goal was to see if boosting the body's immune system could attack the cancer cells. The trial was stopped …

This study tested a special fluorescent dye called tozuleristide that is designed to stick to oral cancer cells. During surgery, surgeons used a special camera to see the glowing dye, which helped them better tell the difference between cancerous and healthy tissue. The trial aim…

This study tested two educational programs designed to help parents with late-stage, non-curable cancer communicate with their children aged 5-17. The goal was to improve the parent-child relationship, boost the parent's confidence in discussing the illness, and reduce anxiety an…

This study offered genetic testing to 799 men whose prostate cancer had spread to other parts of the body. Researchers tested saliva samples for inherited cancer-risk genes to understand how common these genetic changes are in this patient group. The study also explored participa…

This study tested a special type of scan to see if it could accurately measure how well the liver is working in patients with liver cancer. The goal was to see if tracking liver function before, during, and after standard treatments like radiation or surgery could help doctors pl…